New study tests safer dosing of Heart-Stabilizing drug during breathing tube insertion
NCT ID NCT06327399
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two methods of giving the drug dexmedetomidine to 70 adults during intubation (placing a breathing tube). One group received a slow infusion over 10 minutes, the other a quick bolus over 60 seconds. The goal was to see which method causes fewer changes in heart rate and blood pressure. Researchers also tracked any episodes of very slow heart rate or low blood pressure that needed rescue medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine
What this could lead to
If it works, this could point toward a safer way to give dexmedetomidine during intubation, reducing heart rate and blood pressure swings.
What could go wrong
This is a small, completed Phase 2 trial with only 70 participants. Results may not apply to all patients, and the drug can still cause slow heart rate or low blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University Hospitals
Giza, Giza Governorate, 11562, Egypt